| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |